Search company, investor...
Groupe Point Vision company logo

Groupe Point Vision


Corporate Majority | Acquired

Total Raised


About Groupe Point Vision

Operator of ophthalmology centers. The company currently operates centers offering ophthalmology services. It offers to book an appointment taking place within the next 48 hours. On October 14th, 2021, Ares Management acquired a majority stake in Groupe Point Vision. The terms of the transaction were not disclosed.

Headquarters Location

21 rue Auber

Paris, 75009,


33 1 44 56 05 21

Missing: Groupe Point Vision's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Groupe Point Vision's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Groupe Point Vision Frequently Asked Questions (FAQ)

  • Where is Groupe Point Vision's headquarters?

    Groupe Point Vision's headquarters is located at 21 rue Auber, Paris.

  • What is Groupe Point Vision's latest funding round?

    Groupe Point Vision's latest funding round is Corporate Majority.

  • How much did Groupe Point Vision raise?

    Groupe Point Vision raised a total of $12.52M.

  • Who are the investors of Groupe Point Vision?

    Investors of Groupe Point Vision include Ares Management, Bpifrance, Abenex, Helse Capital, Jaina Capital and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.